Some points.
The ME-ICC says: "The label chronic fatigue syndrome (CFS) has persisted for many years because of the lack of knowledge of the aetiological agents and the disease process. In view of more recent research and clinical experience that strongly point to widespread inflammation and multisystemic neuropathology, it is more appropriate and correct to use the term myalgic encephalomyelitis (ME) because it indicates an underlying pathophysiology." This is the first sentence of the article.
So, is this saying that there are two diseases or one disease that has been misnamed, but for which enough research has come in showing a more appropriate name?
It also says, "Myalgic encephalomyelitis (ME), also referred to in the literature as chronic fatigue syndrome (CFS), is a complex disease involving profound dysregulation of the central nervous system (CNS) [13] and immune system [48], dysfunction of cellular energy metabolism and ion transport [911] and cardiovascular abnormalities [1214]."
So, is it saying there are two diseases, or one disease that is referred to in the literature by two names?
The studies referred to include:
- PET in Chronic Fatigue Syndrome: preliminary data: http://www.ncbi.nlm.nih.gov/pubmed/9790483 Cohort was "18 patients who fulfilled the criteria of the working case definition of CFS"
- Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome: http://www.ncbi.nlm.nih.gov/pubmed/11328679 I don't see any description in the abstract of the cohort criteria.
- Chronic fatigue syndrome and the central nervous system: http://chemport.cas.org/cgi-bin/sdc...tlWitLvN&md5=2b0202c73391c9c8d280ed943d1c3bea In the abstract, I don't see a description of the cohort criteria.
- A formal analysis of cytokine networks in chronic fatigue syndrome:http://www.ncbi.nlm.nih.gov/pubmed/20447453 I don't see a description of the cohort criteria in the cohort.
- Immunological aspects of chronic fatigue syndrome: http://www.ncbi.nlm.nih.gov/pubmed/18801465 As for the cohort criteria, it says, "(CFS) is a specific clinical condition that characterises unexplained disabling fatigue and a combination of non-specific accompanying symptoms for at least 6 months."
- Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipetpidyl peptidase IV/CD26. As for cohort, it says, "Diagnosis using the case definition [1] requires the exclusion of any other medical explanation for these symptoms, yielding an inefficient, slow, error prone process." That [1] refers to Fukuda.
Ok, I will stop there. So, is the ME-ICC claiming some features of ME by using evidence from studies in CFS patients? Or, is it claiming features of one disease using evidence from studies of that disease, but saying that evidence shows the disease should no longer be called "CFS"? If the ME-ICC is claiming features of ME to the exclusion of CFS (even Fukuda criteria) patients, then why didn't they refer to the ME studies with the ME criteria? How can ME-ICC have any credibility if the studies they refer to are of people with a different illness? Or is it in fact just one illness, that should be called ME? Does that mean that these findings apply only to Fukuda patients and therefore, only the UK studies of ME are to be applied to ME patients? Or, are is there one disease which some studies refer to as "CFS" some refer to "ME/CFS" and others refer to a "ME" and different criteria are being used, but it is one disease?
The ME-ICC says, "Using fatigue as a name of a disease gives it exclusive emphasis and has been the most confusing and misused criterion. No other fatiguing disease has chronic fatigue attached to its name e.g. cancer/chronic fatigue, multiple sclerosis/chronic fatigue except ME/CFS." So, is this saying CFS is a different illness or that CFS is not an appropriate name for the illness, when compared to the names of other illnesses?
Of course, the ME-ICC refers to the illness as "ME" in many places, because it is saying that is the better term for, as it says often, "the disease."
The ME-ICC also states: "Jason et al. [18] suggest that there are flaws in Reeves methodology because it is possible to meet the empirical criteria for ME without having any physical symptoms and it does not discriminate patients with ME/CFS from those with major depressive disorder." So the ME-ICC does refer to "ME/CFS."
While it says in the conclusion that those who meet the ME-ICC should be taken out of Reeves and NICE, it says nothing about separating the ME patients from Fukuda. In fact, to my reading, this is proposed to replace Fukuda for the criteria for "the disease." This is especially evident that the proof for this new criteria largely relies on findings in Fukuda patients.
Also, one of the scientists who are part of the ME-ICC is Dr. Nancy Klimas. And at the CFSC, Klimas was on the subcommittee that brought forward the recommendation, which CFSAC approved unanimously, to move CFS to the same code as ME. And Klimas said: "The concept here is that Option 1 was, in the feeling of our subcommittee, the best of the options to be lumpers rather than splitters on the terminology of ME/CFS and post viral syndrome, put that all together, with the idea that we are moving toward name change and the name change is likely to not be multiple names. And to have multiple divisions is going to be rather difficult when we have this ICD-10 thing come upon us for quite some time. If we could put things under a single code, I think we are going to be more successful in our name change effort."
Dr. David Bell is also included in the ME-ICC. And he was on CFSAC when they recommended CFS be moved to neurological.
Additionally, Dr. Anthony Komaroff was asked in 2010: "Is CFS a neurological disease?"
His answer is: "I would certainly say, as I have said today, that there is now abundant evidence of measurable abnormalities in the central nervous system and the autonomic nervous system in people with this illness. So that makes it neurological and thats why I think it makes sense, as Dr. Gerwin said, to call it myalgic encephalomyelitis or encephalopathy, because, I think, those two words adequately classify or describe an underlying biology that tests have shown to be the case."
Here is a link to his statement:
http://www.masscfids.org/videofiles/Questions/Questions.html Go to question #21
And this is interesting, if ME and CFS are different diseases, then who in the US is studying ME patients? The Lights published about CFS patients. WPI published about CFS patients (Fukuda and after publication, said they met CCC, which is ME/CFS). Klimas publishes studies of CFS patients. Chia, Natelson, Komaroff, Montoya, Lo, etc. What patients are used in their studies, the ones that shows biological abnormalities in the brain, immune system, etc.? It is Fukuda CFS patients. So, what studies have been done in ME patients? none in the US, that I know of.
Tina